Genetic Technologies (GENE) Competitors $0.76 0.00 (0.00%) (As of 12/16/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends GENE vs. HCWB, NRXP, RLMD, SLGL, KZIA, AIM, ACXP, AWH, PMCB, and IPAShould you be buying Genetic Technologies stock or one of its competitors? The main competitors of Genetic Technologies include HCW Biologics (HCWB), NRx Pharmaceuticals (NRXP), Relmada Therapeutics (RLMD), Sol-Gel Technologies (SLGL), Kazia Therapeutics (KZIA), AIM ImmunoTech (AIM), Acurx Pharmaceuticals (ACXP), Aspira Women's Health (AWH), PharmaCyte Biotech (PMCB), and ImmunoPrecise Antibodies (IPA). These companies are all part of the "pharmaceutical products" industry. Genetic Technologies vs. HCW Biologics NRx Pharmaceuticals Relmada Therapeutics Sol-Gel Technologies Kazia Therapeutics AIM ImmunoTech Acurx Pharmaceuticals Aspira Women's Health PharmaCyte Biotech ImmunoPrecise Antibodies Genetic Technologies (NASDAQ:GENE) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, community ranking, profitability, earnings and analyst recommendations. Is GENE or HCWB more profitable? Genetic Technologies has a net margin of 0.00% compared to HCW Biologics' net margin of -1,067.82%. Genetic Technologies' return on equity of 0.00% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Genetic TechnologiesN/A N/A N/A HCW Biologics -1,067.82%-2,516.84%-132.95% Does the media refer more to GENE or HCWB? In the previous week, Genetic Technologies had 5 more articles in the media than HCW Biologics. MarketBeat recorded 6 mentions for Genetic Technologies and 1 mentions for HCW Biologics. HCW Biologics' average media sentiment score of 1.43 beat Genetic Technologies' score of 0.31 indicating that HCW Biologics is being referred to more favorably in the news media. Company Overall Sentiment Genetic Technologies Neutral HCW Biologics Positive Which has more volatility and risk, GENE or HCWB? Genetic Technologies has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Does the MarketBeat Community favor GENE or HCWB? Genetic Technologies received 155 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 55.33% of users gave Genetic Technologies an outperform vote. CompanyUnderperformOutperformGenetic TechnologiesOutperform Votes16155.33% Underperform Votes13044.67% HCW BiologicsOutperform Votes6100.00% Underperform VotesNo Votes Do insiders and institutionals have more ownership in GENE or HCWB? 0.6% of Genetic Technologies shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 6.5% of Genetic Technologies shares are held by company insiders. Comparatively, 49.9% of HCW Biologics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher earnings and valuation, GENE or HCWB? Genetic Technologies has higher revenue and earnings than HCW Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenetic Technologies$7.66M0.44-$7.88MN/AN/AHCW Biologics$3.50M3.58-$24.99M-$1.00-0.33 SummaryGenetic Technologies beats HCW Biologics on 8 of the 13 factors compared between the two stocks. Ad Wall Street StarHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.Click here to learn more about the booming eHealth industry - and see which microcap will be at the Get Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for GENE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENE vs. The Competition Export to ExcelMetricGenetic TechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.37M$2.98B$5.14B$9.31BDividend YieldN/A1.85%4.81%4.06%P/E RatioN/A46.24135.1817.53Price / Sales0.44440.311,235.42140.39Price / CashN/A182.1340.6537.95Price / Book3.063.924.884.92Net Income-$7.88M-$42.03M$118.97M$225.78M7 Day PerformanceN/A-3.37%16.19%-1.58%1 Month PerformanceN/A7.95%16.02%6.67%1 Year Performance-72.58%21.00%34.95%22.48% Genetic Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050HCWBHCW Biologics1.9783 of 5 stars$0.39-2.5%N/A-70.2%$14.78M$2.84M0.0040Short Interest ↓Positive NewsNRXPNRx Pharmaceuticals2.1931 of 5 stars$1.22flat$32.00+2,523.0%-95.2%$14.75MN/A0.002Gap UpRLMDRelmada Therapeutics4.3789 of 5 stars$0.48+3.8%$4.25+794.7%-85.4%$14.33MN/A-0.1610Gap DownHigh Trading VolumeSLGLSol-Gel Technologies3.1206 of 5 stars$0.50-4.4%$5.00+899.6%-50.1%$13.94M$1.55M0.0050Gap DownKZIAKazia Therapeutics2.4059 of 5 stars$4.12-5.9%$20.00+385.4%-15.0%$13.72M$2.31M0.0012AIMAIM ImmunoTech2.0685 of 5 stars$0.21+2.3%$3.00+1,316.4%-55.5%$13.51M$190,000.00-0.4420News CoverageGap DownACXPAcurx Pharmaceuticals2.0422 of 5 stars$0.79+4.8%$12.00+1,427.1%-75.3%$13.27MN/A0.003High Trading VolumeAWHAspira Women's Health1.4879 of 5 stars$0.76+1.3%$4.40+478.9%-72.5%$12.67M$9.15M0.00110Gap UpPMCBPharmaCyte Biotech1.2285 of 5 stars$1.64+0.0%N/A-22.3%$12.60MN/A2.482Earnings ReportIPAImmunoPrecise Antibodies3 of 5 stars$0.44+14.5%$6.00+1,279.0%-68.5%$12.54M$18.16M-0.5880Gap UpHigh Trading Volume Related Companies and Tools Related Companies HCWB Alternatives NRXP Alternatives RLMD Alternatives SLGL Alternatives KZIA Alternatives AIM Alternatives ACXP Alternatives AWH Alternatives PMCB Alternatives IPA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GENE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genetic Technologies Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genetic Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
